| Discuss | Index | Tracked By |
Unique Strategy Generates Big Returns for Baupost
ENZN VSAT VOXX MGAM AOI THRX CITGQ CSE ELOS NWSA Linked by tickerspy blog ( track newsfeed | ignore newsfeed ) - November 13, 08:52AM from (www.tickerspy.com) Though typically described as a value investor, Seth Klarman's strategy - and his remarkable track record - are difficult to define. more ...
Syneron Medical Posts Q3 Loss of 20c, Misses Views by 5c
ELOS Linked by StreetInsider ( track newsfeed | ignore newsfeed ) - November 09, 06:52AM from (www.streetinsider.com) more ...
Syneron Reports Third Quarter 2009 Financial Results
ELOS Linked by marketwire ( track newsfeed | ignore newsfeed ) - November 09, 05:45AM from (www2.marketwire.com) Syneron Medical Ltd. (NASDAQ: ELOS) more ...
Cutera Reports Q3 Results
CUTR Linked by StreetInsider ( track newsfeed | ignore newsfeed ) - November 02, 04:44PM from (www.streetinsider.com) more ...
Syneron Medical to Announce Third Quarter 2009 Financial Results on November 9th, 2009
ELOS Linked by marketwire ( track newsfeed | ignore newsfeed ) - October 29, 08:44AM from (www2.marketwire.com) Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elos(TM) combined-energy medical more ...
Palomar Medical Reports Financial Results for Third Quarter 2009
PMTI Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - October 29, 08:00AM BURLINGTON, Mass., Oct. 29 /PRNewswire-FirstCall/ -- Palomar Medical Technologies, Inc. (Nasdaq: PMTI), a leading researcher more ...
Cynosure Posts Q3 Loss of $0.15
CYNO Linked by StreetInsider ( track newsfeed | ignore newsfeed ) - October 27, 08:24AM from (www.streetinsider.com) more ...
Cynosure Reports Third Quarter 2009 Financial Results
CYNO Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - October 27, 08:00AM WESTFORD, Mass., Oct. 27 /PRNewswire-FirstCall/ -- Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of more ...
Candela Announces Results for the First Fiscal Quarter 2010
CLZR Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - October 20, 04:05PM from (www.businesswire.com) Candela Corporation (NASDAQ:CLZR) today reported that revenues for the quarter ended September 26, 2009 were $26.2 million. more ...
Palomar Medical upgraded to "buy"
PMTI Linked by newratings ( track newsfeed | ignore newsfeed ) - October 19, 11:43AM from (www.newratings.com) NEW YORK, October 19 (newratings.com) - Analysts at Brean Murray upgrade Palomar Medical (ticker: PMTI) from "hold" more ...
Closing Bell: Not all earnings created equal (GOOG, BAC, GE, AMD, PMTI, JNJ)
AMD GE BAC JNJ PMTI GOOG Linked by BloggingStocks ( track newsfeed | ignore newsfeed ) - October 16, 04:43PM from (www.pheedcontent.com) Today's earnings were deemed a disappointment despite some bottom-line comfort here. A weaker University of Michigan Consumer more ...
Palomar Dumped by J&J
JNJ PMTI Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - October 16, 10:16AM from (feedproxy.google.com) Palomar Medical Technologies Inc. (NASDAQ: PMTI) is getting hit very hard. The company issued a press release saying "Palomar more ...
Candela Corporation to Report Fiscal Year 2010 First Quarter Financial Results and Host Conference Call on October 20
CLZR Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - October 15, 04:20PM from (www.businesswire.com) Candela Corporation (NASDAQ: CLZR) will report financial results for its first quarter on Tuesday, October 20, 2009 at approximately more ...
Syneron Medical upgraded to "outperform"
ELOS Linked by newratings ( track newsfeed | ignore newsfeed ) - September 18, 12:43PM from (www.newratings.com) NEW YORK, September 18 (newratings.com) - Analysts at Oppenheimer & Co upgrade Syneron Medical (ticker: ELOS) from "perform" more ...
Syneron Medical Ltd. and Candela Corporation to Merge Creating a Leading Global Aesthetic Device Company
CLZR ELOS Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - September 09, 05:00AM from (www.businesswire.com) Syneron Medical Ltd. (NASDAQ:ELOS) and Candela Corporation (NASDAQ:CLZR) announced today that they have entered into a definitive more ...
Eclectic Strategy Has Generated Huge Returns for Baupost
AOI LMDIA CIT CSE ELOS BBEP Linked by tickerspy blog ( track newsfeed | ignore newsfeed ) - August 20, 09:43AM from (www.tickerspy.com) Though typically described as a value investor, Seth Klarman's strategy - and his remarkable track record - are unique. more ...
Candela Corp. Reports Q4 Earnings of 2c
CLZR Linked by StreetInsider ( track newsfeed | ignore newsfeed ) - August 18, 04:07PM from (www.streetinsider.com) more ...
Candela Announces Results for the Fourth Fiscal Quarter and Full Year
CLZR Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - August 18, 04:05PM from (www.businesswire.com) Candela Corporation (NASDAQ:CLZR) today reported that revenues for the quarter ended June 27, 2009 were $31.4 million. Income more ...
Syneron Medical Reports Better-Than-Expected Q2 Results
ELOS Linked by StreetInsider ( track newsfeed | ignore newsfeed ) - August 13, 08:30AM from (www.streetinsider.com) more ...
Syneron Reports Second Quarter 2009 Results
ELOS Linked by marketwire ( track newsfeed | ignore newsfeed ) - August 13, 06:30AM from (www2.marketwire.com) Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elos(TM) combined-energy medical more ...
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Home | About | Register | My tickerspy | Logout | Web site design by LightMix |
| © 2009 Indie Research, LLC. All rights reserved. | |
---
Institutional Holdings Disclaimer Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter. Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time. tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors. THE INFORMATION PROVIDED TO YOU HEREUNDER IS PROVIDED "AS IS" AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, INDIE RESEARCH, LLC AND IT LICENSORS, BUSINESS ASSOCIATES AND SUPPLIERS DISCLAIM ALL WARRANTIES WITH RESPECT TO THE SAME, EXPRESS, IMPLIED AND STATUTORY, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, COMPLETENESS AND NON-INFRINGEMENT. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER INDIE RESEARCH, LLC NOR ITS OFFICERS, MEMBERS, DIRECTORS, PARTNERS, AFFILIATES, BUSINESS ASSOCIATES, LICNESORS OR SUPPLIERS WILL BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION DAMAGAES FOR LOST PROFITS OR REVENUES, GOODWILL, WORK STOPPAGE, SECURITY BREACHES, VIRUSES, COMPUTER FAILURE OR MALFUNCTION, USE, DATA OR OTHER INTANGIBLE LOSSES OR COMMERCIAL DAMAGES, EVEN IF ANY OF SUCH PARTIES ADVISED OF THE POSSIBILITY OF SUCH LOSSES, ARISING UNDER OR IN CONNECTION WITH THE INFORMATION PROVIDED HEREIN OR ANY OTHER SUBJECT MATTER HEREOF.
|
|